TrumpRX and DTC sales may expand prescription drug access, but they will not solve the affordability crisis by themselves.
The cost of GLP-1 medications to group health plans continues to increase rapidly as FDA approval expands and the percentage of participants and beneficiaries taking GLP-1 medications rises. This ...
A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the private prescription drug insurance model, researchers say. Subscribe to our ...
The direct-to-consumer model gutted the markup on everything from eyeglasses to mattresses. Now it’s coming for one of retail’s most markup-heavy categories: Swiss luxury watches. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results